CN102698088B - 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 - Google Patents
治疗鸡新城疫的中药组合物、饲料、制备方法和应用 Download PDFInfo
- Publication number
- CN102698088B CN102698088B CN2012100076938A CN201210007693A CN102698088B CN 102698088 B CN102698088 B CN 102698088B CN 2012100076938 A CN2012100076938 A CN 2012100076938A CN 201210007693 A CN201210007693 A CN 201210007693A CN 102698088 B CN102698088 B CN 102698088B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- weight portions
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 113
- 239000000203 mixture Substances 0.000 title claims abstract description 103
- 208000010359 Newcastle Disease Diseases 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims description 17
- 238000011282 treatment Methods 0.000 claims abstract description 39
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 14
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 230000001476 alcoholic effect Effects 0.000 claims description 32
- 241000628997 Flos Species 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 19
- 238000010298 pulverizing process Methods 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 241000756943 Codonopsis Species 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 13
- 238000001556 precipitation Methods 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims description 3
- 238000006703 hydration reaction Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 35
- 241000287828 Gallus gallus Species 0.000 abstract description 26
- 208000024891 symptom Diseases 0.000 abstract description 21
- 230000001717 pathogenic effect Effects 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 11
- 238000005728 strengthening Methods 0.000 abstract description 9
- 206010052804 Drug tolerance Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 231100000674 Phytotoxicity Toxicity 0.000 abstract 1
- 235000003417 Plumeria rubra f acutifolia Nutrition 0.000 abstract 1
- 244000040691 Plumeria rubra f. acutifolia Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 35
- 239000000243 solution Substances 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 25
- 210000002784 stomach Anatomy 0.000 description 24
- 235000013330 chicken meat Nutrition 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 21
- 201000010099 disease Diseases 0.000 description 20
- 210000000214 mouth Anatomy 0.000 description 20
- 238000012360 testing method Methods 0.000 description 16
- 208000032843 Hemorrhage Diseases 0.000 description 15
- 208000001848 dysentery Diseases 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 210000003038 endothelium Anatomy 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 10
- 230000001154 acute effect Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 241000700605 Viruses Species 0.000 description 9
- 210000004877 mucosa Anatomy 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 231100000915 pathological change Toxicity 0.000 description 7
- 230000036285 pathological change Effects 0.000 description 7
- 230000001047 pyretic effect Effects 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 206010034754 petechiae Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 241000271566 Aves Species 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 206010014599 encephalitis Diseases 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 210000001835 viscera Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000002155 anti-virotic effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 231100000668 minimum lethal dose Toxicity 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 238000003307 slaughter Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000252983 Caecum Species 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 206010014080 Ecchymosis Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 206010029216 Nervousness Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229960001280 amantadine hydrochloride Drugs 0.000 description 3
- WOLHOYHSEKDWQH-UHFFFAOYSA-N amantadine hydrochloride Chemical compound [Cl-].C1C(C2)CC3CC2CC1([NH3+])C3 WOLHOYHSEKDWQH-UHFFFAOYSA-N 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004534 cecum Anatomy 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000000762 glandular Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 3
- 229960004306 sulfadiazine Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 239000005723 virus inoculator Substances 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000711404 Avian avulavirus 1 Species 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 239000004258 Ethoxyquin Substances 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229960003805 amantadine Drugs 0.000 description 2
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000009361 aviculture Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002498 deadly effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 2
- 229940093500 ethoxyquin Drugs 0.000 description 2
- 235000019285 ethoxyquin Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 229960000329 ribavirin Drugs 0.000 description 2
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000001562 sternum Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- BHELIUBJHYAEDK-OAIUPTLZSA-N Aspoxicillin Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3[C@H](C(C)(C)S[C@@H]32)C(O)=O)=O)NC(=O)[C@H](N)CC(=O)NC)=CC=C(O)C=C1 BHELIUBJHYAEDK-OAIUPTLZSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 101100492584 Caenorhabditis elegans ast-1 gene Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 206010017788 Gastric haemorrhage Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010058680 Nipple swelling Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000004876 tela submucosa Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
分组 | 总数 | 死亡(只) | 死亡率(%) |
1(30g/kg) | 20 | 0 | 0 |
2(18g/kg) | 20 | 0 | 0 |
3(6g/kg) | 20 | 0 | 0 |
对照组 | 20 | 0 | 0 |
分组 | 肝脏指数 | 心脏指数 | 肾脏指数 | 肺脏指数 | 脾脏指数 |
1(30g/kg) | 5.82±0.13 | 0.75±0.02 | 1.27±0.16 | 0.69±0.03 | 0.50±0.03 |
2(18g/kg) | 5.73±0.17 | 0.77±0.07 | 1.30±0.09 | 0.66±0.05 | 0.52±0.04 |
3(6g/kg) | 5.85±0.10 | 0.72±0.11 | 1.33±0.12 | 0.73±0.03 | 0.49±0.03 |
对照组 | 5.86±0.21 | 0.70±0.02 | 1.35±0.11 | 0.70±0.07 | 0.50±0.02 |
分组 | 总数 | ALT | AST |
1(30g/kg) | 20 | 36.71±3.12 | 127.13±11.39 |
2(18g/kg) | 20 | 38.23±2.19 | 129.35±11.53 |
3(6g/kg) | 20 | 37.30±2.01 | 131.67±16.21 |
对照组 | 20 | 40.12±5.33 | 133.29±17.58 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100076938A CN102698088B (zh) | 2012-01-05 | 2012-01-05 | 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100076938A CN102698088B (zh) | 2012-01-05 | 2012-01-05 | 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102698088A CN102698088A (zh) | 2012-10-03 |
CN102698088B true CN102698088B (zh) | 2013-10-30 |
Family
ID=46891335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100076938A Expired - Fee Related CN102698088B (zh) | 2012-01-05 | 2012-01-05 | 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102698088B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103598460B (zh) * | 2013-10-25 | 2015-10-28 | 青岛华仁技术孵化器有限公司 | 用于预防鸡传染性支气管炎的饲料 |
CN103859215B (zh) * | 2014-03-11 | 2015-07-01 | 山东新希望六和集团有限公司 | 一种蛋鸡产蛋期饲料及其制备方法 |
CN104431460A (zh) * | 2014-11-20 | 2015-03-25 | 惠州市欧野科技有限公司 | 生物饲料 |
CN105232747A (zh) * | 2015-10-12 | 2016-01-13 | 卢仁华 | 鸡新城疫病毒感染治疗药剂 |
CN105748612A (zh) * | 2016-03-30 | 2016-07-13 | 南宁市百济生物工程有限公司 | 一种治疗鸭病的中药制剂 |
CN106214862B (zh) * | 2016-08-18 | 2019-10-25 | 山东省农业科学院家禽研究所 | 一种防治鸡非典型性新城疫的中兽药口服液及其制备方法 |
CN107307217A (zh) * | 2017-07-13 | 2017-11-03 | 安徽省浩然孔雀养殖有限公司 | 一种防冶鸡新城疫的孔雀饲料 |
CN113506032B (zh) * | 2021-07-27 | 2023-01-06 | 贵州纳雍源生牧业股份有限公司 | 一种养鸡场循环生态利用系统 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690810A (zh) * | 2009-10-21 | 2010-04-07 | 张勇飞 | 一种鸡新城疫、传染性支气管炎、减蛋综合征、禽流感四联灭活疫苗佐剂及其制备方法 |
CN101804162A (zh) * | 2010-04-19 | 2010-08-18 | 河南工业大学 | 抗鸡新城疫病毒的中药组合物及制备方法 |
CN102205036A (zh) * | 2011-05-10 | 2011-10-05 | 蒋保珍 | 一种治疗鸡新城疫病的中药组合物及其制备方法 |
-
2012
- 2012-01-05 CN CN2012100076938A patent/CN102698088B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690810A (zh) * | 2009-10-21 | 2010-04-07 | 张勇飞 | 一种鸡新城疫、传染性支气管炎、减蛋综合征、禽流感四联灭活疫苗佐剂及其制备方法 |
CN101804162A (zh) * | 2010-04-19 | 2010-08-18 | 河南工业大学 | 抗鸡新城疫病毒的中药组合物及制备方法 |
CN102205036A (zh) * | 2011-05-10 | 2011-10-05 | 蒋保珍 | 一种治疗鸡新城疫病的中药组合物及其制备方法 |
Non-Patent Citations (6)
Title |
---|
中草药防治畜禽病毒病的研究进展;张展 等;《畜牧兽医杂志》;20081231;第27卷(第3期);第43-44,46页 * |
中药四君子汤对肉鸡新城疫疫苗免疫效果的影响;黄雪泉 等;《江西畜牧兽医杂志》;20091231(第3期);第19-21页 * |
中药防治鸡新城疫研究进展;石达友 等;《中兽医医药杂志》;20101231(第3期);第72-74页 * |
张展 等.中草药防治畜禽病毒病的研究进展.《畜牧兽医杂志》.2008,第27卷(第3期),第43-44,46页. |
石达友 等.中药防治鸡新城疫研究进展.《中兽医医药杂志》.2010,(第3期),第72-74页. |
黄雪泉 等.中药四君子汤对肉鸡新城疫疫苗免疫效果的影响.《江西畜牧兽医杂志》.2009,(第3期),第19-21页. |
Also Published As
Publication number | Publication date |
---|---|
CN102698088A (zh) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698088B (zh) | 治疗鸡新城疫的中药组合物、饲料、制备方法和应用 | |
CN102698123B (zh) | 治疗猪传染性胃肠炎的中药组合物、饲料、制备和应用 | |
CN103142892B (zh) | 一种用于治疗鸡痘的饲料组合物 | |
CN104187172B (zh) | 用于治疗乌龟肠胃炎病的功能性饲料及其制备方法 | |
CN103495091B (zh) | 用于预防柔嫩艾美尔球虫感染的中药免疫制剂 | |
CN102526525A (zh) | 一种用于治疗猪传染性胃肠炎的中药组合物 | |
CN102552656B (zh) | 一种用于治疗鸡大肠杆菌病的中药组合物 | |
CN103719609A (zh) | 一种哺乳期母猪饲料及其制备方法 | |
CN102640876A (zh) | 用于治疗鸭病毒性肝炎的饲料、注射液和制备方法 | |
CN103381237B (zh) | 治疗猪肺疫的中药组合物和应用 | |
CN102488847B (zh) | 治疗鸡传染性法氏囊病的中药组合物、制备方法和应用 | |
CN104256166A (zh) | 一种用于治疗牛蓝舌病的功能性饲料及其制备方法 | |
CN104256165B (zh) | 用于防治慢性型猪瘟疫的功能性饲料及其制备方法 | |
CN102988760B (zh) | 治疗鹦鹉热衣原体病的中药组合物 | |
CN103494927B (zh) | 一种用于治疗鸡呼吸道疾病的中药组合物及其制备方法 | |
CN103202908B (zh) | 预防和治疗大肠杆菌病的中草药饲料添加剂 | |
CN102526510A (zh) | 一种用于预防和治疗鸭病毒性肝炎的中药组合物 | |
CN102698158B (zh) | 防治鸡肾型传染性支气管炎的中药、制备方法和饲料 | |
CN102552657B (zh) | 一种用于治疗鸡新城疫病的中药组合物 | |
CN102988769B (zh) | 治疗鸡球虫病的中药组合物和应用 | |
CN106511675A (zh) | 一种用于防治家禽疾病的药及其制备方法 | |
CN103652490B (zh) | 用于治疗猪蓝耳病的猪饲料及其制备方法 | |
CN105250972A (zh) | 一种防治家禽腺胃炎的中药组合物及其制备方法和用途 | |
CN103393891B (zh) | 一种抗病毒兽用复方中药及其制备方法和用途 | |
CN102657772B (zh) | 用于治疗鸡葡萄球菌病的煎剂、饲料和制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Free format text: FORMER OWNER: LIU XIA Effective date: 20130929 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 237222 LU'AN, ANHUI PROVINCE TO: 266071 QINGDAO, SHANDONG PROVINCE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130929 Address after: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Applicant after: Qingdao Huaren Technology Incubator Co., Ltd. Address before: 237222 Anhui Province, Mount Holyoke county but the streets but Jia Miao Zhen Jia Miao Cun Applicant before: Liu Xia |
|
ASS | Succession or assignment of patent right |
Owner name: FUJIAN WUPING FENGBEN XIANGDONG CHICKEN DEVELOPMEN Free format text: FORMER OWNER: QINGDAO HUAREN TECHNOLOGY INCUBATOR CO., LTD. Effective date: 20141211 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266071 QINGDAO, SHANDONG PROVINCE TO: 364300 LONGYAN, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141211 Address after: 364300 Longyan City, Fujian province Wuping County town of Wucun high ten party Patentee after: Wuping of Fujian Feng Ben as the hole chicken Development Co. Ltd. Address before: 266071 Shandong city of Qingdao province Hongkong City Road No. 32 floor 801-A room 8 Patentee before: Qingdao Huaren Technology Incubator Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131030 Termination date: 20170105 |